Continuous and direct infusion of drug solutions in the brain of awake animals: Implementation, strengths and pitfalls

Brain Research Protocols

Volumn 1, Issue 1, 1997, Pages 57-69

  Kasamatsu, Takuji ^a   Schmidt, Eric K ^a  

^a SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

Author keywords

Chronic drug infusion; Dynamic concentration gradient; In vivo brain pharmacology; Osmotic minipump

Indexed keywords

DIHYDROALPRENOLOL; DOPAMINE BETA MONOOXYGENASE; DRUG VEHICLE; NORADRENALIN; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CANNULA; CAT; CONTINUOUS INFUSION; LEARNING; MEMORY; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; VISUAL CORTEX; WAKEFULNESS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CATS; EVALUATION STUDIES; INFUSION PUMPS; NERVE FIBERS; NERVE REGENERATION; OXIDOPAMINE; SOLUTIONS;

EID: 0031400002     PISSN: 1385299X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1385-299X(96)00008-6     Document Type: Article

References (46)

1. Barone, S., Tandon, P., McGinty, J.F. and Tilson, H.A., The effects of NGF and fetal cell transplants on spatial learning after intradentate administration of colchicine, Exp. Neurol., 114 (1991) 351-363.
2. Bear, M.F., Kleinschmidt, A., Gu, Q. and Singer, W., Disruption of experience-dependent synaptic modifications in striate cortex by infusion of a NMDA receptor antagonist, J. Neurosci., 10 (1990) 909-925.
3. Bowers, C.Y. and Folkers, K., Contraception and inhibition of hormone active analogs and antagonists, Biochem. Biophys. Res. Commun., 72 (1976) 1003-1007.
4. Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council, Guide for the Care and Use of Laboratory Animals, U.S. Dept. Health and Human Services, NIH Publication No. 86-23, revised 1985.
5. Evans, B.K., Armstrong, S., Singer, G., Cook, R.D. and Burnstock, G., Intracranial injection of drugs: comparison of diffusion of 6-OHDA and guanethidine, Pharmacol. Biochem. Behav., 3 (1975) 205-217.
6. Fischer, W., Björklund, A., Chen, K. and Gage, F.H., NGF improves spatial memory in aged rodents as a function of age, J. Neurosci., 11 (1991) 1889-1906.
7. Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma Jr., F.J. and Sibley, D.R., D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
8. Gronan, R.J. and York, D.H., Effects of chronic intraventricular administration of angiotensin II on drinking behavior and blood pressure, Pharmacol. Biochem. Behav., 10 (1979) 121-126.
9. Gu, Q., Bear, M.F. and Singer, W., Blockade of NMDA-receptors prevents ocularity changes in kitten visual cortex after reversed monocular deprivation, Dev. Brain Res., 47 (1989) 281-288.
10. Hauger, R.L., Aguilera, G. and Catt, K.J., Angiotensin II regulates its receptor sites in the adrenal glomerulosa zone, Nature, 271 (1978) 176-177.
11. Haycock, D.A. and Bear, M.F., The stability of 6-hydroxydopamine under minipump conditions, Exp. Brain Res., 56 (1984) 183-186.
12. Hökfelt, T. and Ungerstedt, U., Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurons: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system, Brain Res., 60 (1973) 269-297.
13. Imamura, K. and Kasamatsu, T., Ocular dominance plasticity restored by NA infusion to aplastic visual cortex of anesthetized and paralyzed kittens, Exp. Brain Res., 87 (1991) 309-318.
14. Imamura, K. and Kasamatsu, T., Interaction of noradrenergic and cholinergic systems in regulation of ocular dominance plasticity, Neurosci. Res., 6 (1989) 519-536.
15. Jonsson, G., Chemical neurotoxins as denervation tools in neurobiology, Annu. Rev. Neurosci., 3 (1980) 169-187.
16. Kasamatsu, T., Neuronal plasticity maintained by the central norepinephrine system in the cat visual cortex, Prog. Psychobiol. Physiol. Psychol., 10 (1983) 1-112.
17. Kasamatsu, T., Studies on regulation of ocular dominance plasticity: strategies and findings. In A. Albowitz, K. Albus, U. Kuhnt, H.-Ch. Nothdurft and P. Wahle (Eds.), Structural and Functional Organization of the Neocortex, Springer, Berlin, 1994, pp. 68-80.
18. Kasamatsu, T., Ohashi, T. and Imamura, K., Integration of adrenergic and cholinergic regulation in ocular dominance plasticity. Proceedings of the 14th Seiriken Conference on "The Neural Basis of Cortical Plasticity", Biomed. Res., 10, Suppl. 2 (1989) 43-53.
19. Kasamatsu, T., Ohashi, T. and Imamura, K., Lithium reduces ocular dominance plasticity in kitten visual cortex, Brain Res., 558 (1991) 157-162.
20. Kasamatsu, T., Itakura, T. and Jonsson, G., Intracortical spread of exogenous catecholamines: effective concentration for modifying cortical plasticity, J. Pharmacol. Exp. Ther., 217 (1981) 841-850.
21. Kostrzewa, R.M. and Jacobowitz, D.W., Pharmacological action 6-hydroxydopamine, Pharmacol. Rev., 26 (1974) 199-288.
22. Meyers, R.D., Injection of solutions into cerebral tissue: relation between volume and diffusion, Physiol. Behav., 1 (1966) 171-174.
23. Miller, K.D., Chapman, B. and Stryker, M.P., Visual responses in adult cat visual cortex depend on N-methyl-D-aspartate receptors, Proc. Natl. Acad. Sci. USA, 86 (1989) 5186-5187.
24. Morris, R.G.M., Spatial plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5, J. Neurosci., 9 (1989) 3040-3057.
25. 3H]glutamate receptor binding in relation to learning, Behav. Neural Biol., 47 (1987) 333-345.
26. Nakai, K., Jonsson, G. and Kasamatsu, T., Norepinephrinergic reinnervation of cat occipital cortex following localized lesions with 6-hydroxydopamine, Neurosci. Res., 4 (1987) 433-453.
27. Nakai, K., Niiyama, K., Kasamatsu, T., Naka, Y., Itakura, T. and Komai, N., Regeneration of norepinephrine-containing fibers in occipital cortex of adult cats, Brain Res. Bull., 35 (1994) 409-412.
28. Nakai, K. and Kasamatsu, T., Two types of catecholamine containing terminals in cat visual cortex: an ultrastructural study, Acta Histochem. Cytochem., 18 (1985) 323-335.
29. Nishizuka, Y., The molecular heterogeneity of protein kinase C and its implications for cellular regulation, Nature, 334 (1988) 661-665.
30. Obie, J.F. and Cooper, C.W., Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump, J. Pharmacol. Exp. Ther., 209 (1979) 422-428.
31. Poirer, L.J., Langelier, P., Roberge, A., Boucher, R. and Kitsikis, A., Non-specific histopathological changes induced by the intracerebral injection of 6-hydroxydopamine (6-OHDA), J. Neurol. Sci., 16 (1972) 401-416.
32. Reiter, H.O. and Stryker, M.P., Neural plasticity without postsynaptic action potentials: less active inputs become dominant when kitten visual cortical cells are pharmacologically inhibited, Proc. Natl. Acad. Sci. USA, 85 (1988) 3623-3627.
33. Rosen, K.M., McCormack, M.A., Villa-Komaroff, L. and Mower, G., Brief visual experience induces immediate early gene expression in the cat visual cortex, Proc. Natl. Acad. Sci. USA, 89 (1992) 5437-5441.
34. Sendelbeck, S.L. and Urquhart, J., Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion, Brain Res., 328 (1985) 251-258.
35. Shirokawa, T. and Kasamatsu, T., Concentration-dependent suppression by β-adrenergic antagonists of the shift in ocular dominance following monocular deprivation in kitten visual cortex, Neuroscience, 18 (1986) 1035-1046.
36. Siew, C. and Goldstein, D.B., Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence, J. Pharmacol. Exp. Ther., 204 (1978) 541-546.
37. Smits, J.F.M. and Struyker-Boudier, H.A.J., Steady-state disposition of propranolol and its total metabolites in the spontaneously hypertensive rat: chronic subcutaneous versus intracerebroventricular infusion with osmotic minipump, J. Pharmacol. Exp. Ther., 209 (1979) 317-322.
38. Staubli, U., Thibault, O., Di Lorenzo, M. and Lynch, G., Antagonism of NMDA receptors impairs acquisition but not retention of olfactory memory, Behav. Neurosci., 103 (1989) 54-60.
39. Tabakoff, B., Ritzmann, R.F. and Oltmans, G.A., The effect of selective lesions of brain noradrenergic systems on the development of barbiturate tolerance in rats, Brain Res., 176 (1979) 327-336.
40. Ueki, A. and Miyoshi, K., Reversal of learning impairment in ventral globus pallicus-lesioned rats by combination of continuous intracerebroventricular choline infusion and oral cholinergic drug administration, Brain Res., 547 (1991) 99-109.
41. Van Sluyters, R.C. and Oberdorfer, M.D. (Eds.), Preparation and Maintenance of Higher Mammals during Neuroscience Experiments. Report of NIH Workshop, U.S. Dept. Health and Human Services, NIH Publ. No. 91-3207, 1991.
42. Volicer, L., Schmidt, W.K., Hartz, T.P., Klosowicz, B.A. and Meichner, R., Cyclic nucleotides and ethanol tolerance and dependence, Drug Alcohol Depend., 4 (1979) 295-305.
43. Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericaon, H., Yoo, H., Inturrisi, C.E. and Reis, D.J., Antisense oligodeoxynucleotides to NMDA-RI receptor channel protect cortical neurons from excitoxicity and reduce focal ischaemic infarctions, Nature, 363 (1993) 260-263.
44. Wei, E. and Loh, H., Physical dependence on opiate-like peptides, Science, 193 (1976) 1262-1263.
45. Weintraub, H.M., Antisense RNA and DNA, Sci. Am., 262 (1990) 40-46.
46. Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J.R. and Neckers, L.M., Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system, Proc. Natl. Acad. Sci. USA, 90 (1993) 4665-4669.